phosphorylethanolamine has been researched along with Kidney Stones in 2 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Victor, PP | 1 |
| Narayanaswamy, R | 1 |
| Kadry, S | 1 |
| Gurunathan, B | 1 |
| Licata, AA | 1 |
| Radfar, N | 1 |
| Bartter, FC | 1 |
| Bou, E | 1 |
2 other studies available for phosphorylethanolamine and Kidney Stones
| Article | Year |
|---|---|
Identification of novel inhibitor against human phosphoethanolamine cytidylyltransferase from phytochemicals of Citrus sinensis peel extract by in vitro and in silico approach.
Topics: Animals; Calcium Oxalate; Citrus sinensis; Dogs; Humans; Kidney Calculi; Molecular Docking Simulatio | 2023 |
The urinary excretion of phosphoethanolamine in diseases other than hypophosphatasia.
Topics: Adolescent; Adult; Age Factors; Bone Diseases; Child; Circadian Rhythm; Dietary Proteins; Endocrine | 1978 |